Concourse Financial Group Securities’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2736 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4289 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4286 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4324 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4333 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4268 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4221 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4165 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4064 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4034 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3819 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3869 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3818 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3918 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3855 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3745 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3668 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3590 |
|